mhurhangee/ep-ind-claims huggingface dataset:
Method for operating a heat-pump heating arrangement for a building, wherein an averaged heating volumetric flow rate of a heating circuit of the heat-pump heating arrangement is determined, preferably on the basis of a heating volumetric flow rate of the heating circuit of the heat-pump heating arrangement that is ascertained and/or recorded over a predefined first period of time, wherein the averaged heating volumetric flow rate is compared with a predefined first threshold value in a first comparison, characterized in that an averaged external temperature is determined, preferably on the basis of an external temperature outside the building that is ascertained and/or recorded at regular time intervals over the predefined first period of time, wherein the averaged external temperature is compared with a predefined second threshold value, wherein, in a manner dependent on the first comparison and in the case of the predefined second threshold value being fallen below, a predefined heating curve of the heat-pump heating arrangement is adapted on the basis of the averaged external temperature and in particular of a predefined first parameter, wherein the heat-pump heating arrangement is controlled on the basis of the adapted heating curve (200, 207).
An oral pharmaceutical composition comprising an essential oil portion and a carrier oil portion, wherein the essential oil portion consists essentially of • from about 20 vol.-% to about 50 vol.-% of the essential oil derived from Citrus bergamia based on the total volume of the essential oil portion; • from about 20 vol.-% to about 50 vol.-% of the essential oil derived from Matricaria chamomilla based on the total volume of the essential oil portion; • from about 10 vol.-% to about 30 vol.-% of the essential oil derived from Origanum vulgare based on the total volume of the essential oil portion; • from about 5 vol.-% to about 20 vol.-% of the essential oil derived from Juniperus communis based on the total volume of the essential oil portion; and • from about 5 vol.-% to about 20 vol.-% of the essential oil derived from Rosmarinus officinalis based on the total volume of the essential oil portion; and wherein a carrier oil portion comprises a fatty acid. • from about 20 vol.-% to about 50 vol.-% of the essential oil derived from Citrus bergamia based on the total volume of the essential oil portion; • from about 20 vol.-% to about 50 vol.-% of the essential oil derived from Matricaria chamomilla based on the total volume of the essential oil portion; • from about 10 vol.-% to about 30 vol.-% of the essential oil derived from Origanum vulgare based on the total volume of the essential oil portion; • from about 5 vol.-% to about 20 vol.-% of the essential oil derived from Juniperus communis based on the total volume of the essential oil portion; and • from about 5 vol.-% to about 20 vol.-% of the essential oil derived from Rosmarinus officinalis based on the total volume of the essential oil portion; and
A method for producing a resin molded article, comprising step heating a blend comprising at least one member selected from the group consisting of dicyclopentadiene-based monomers, tetracyclododecene-based monomers, and tricyclopentadiene-based monomers, and a metathesis polymerization catalyst to carry out a polymerization curing; and step forming a polyamide-imide layer on a surface of the norbornene-based crosslinked polymer obtained in the step, wherein the polymerization curing of the blend in the step comprises: step (i): heating the blend to a temperature lower than a deactivation temperature of the metathesis polymerization catalyst to carry out a primary curing; and step (ii): heating a cured product obtained in the step (i) to a temperature equal to or higher than a deactivation temperature of the metathesis polymerization catalyst to carry out a secondary curing. step (i): heating the blend to a temperature lower than a deactivation temperature of the metathesis polymerization catalyst to carry out a primary curing; and step (ii): heating a cured product obtained in the step (i) to a temperature equal to or higher than a deactivation temperature of the metathesis polymerization catalyst to carry out a secondary curing.
Method for controlling a work machine, in particular a mobile work machine, and preferably a wheel loader, wherein the work machine comprises at least one combustion engine that can be operated in at least one idle mode, and wherein the method includes the step of reducing the engine speed in the idle mode to below the minimum rotating speed of a certified speed range if at least one condition is satisfied, characterized in that the condition is the elapse of a time period in which the engine runs within the certified speed range in the idle mode, wherein the time period corresponds at least to the longest idle mode phase in the dynamic test cycle ISO 8178/11.
A method of forming a coating on a food or beverage container, the method comprising: providing a coating composition having an emulsion-polymerized latex copolymer dispersed in an aqueous carrier, wherein the emulsion-polymerized latex copolymer is a reaction product of monomers comprising: one or more mono-unsaturated monomers each having a single ethylenically-unsaturated group; and one or more multi-unsaturated monomers each having two or more ethylenically-unsaturated groups, wherein the multi-unsaturated monomer(s) each have a divalent chain length with at least two carbon atoms between at least two of the ethylenically-unsaturated groups, and constitute from 8% by weight to 25% by weight of the monomers used to produce the emulsion-polymerized latex copolymer; wherein the monomers used to produce the emulsion-polymerized latex copolymer are substantially free of oxirane groups, and wherein the coating composition preferably includes less than 1 weight percent, if any, of vegetable oils; spraying the provided coating composition onto an interior surface of the food or beverage container; and curing the sprayed coating composition to substantially remove the aqueous carrier, and provide the coating on the interior surface of the food or beverage container. providing a coating composition having an emulsion-polymerized latex copolymer dispersed in an aqueous carrier, wherein the emulsion-polymerized latex copolymer is a reaction product of monomers comprising: one or more mono-unsaturated monomers each having a single ethylenically-unsaturated group; and one or more multi-unsaturated monomers each having two or more ethylenically-unsaturated groups, wherein the multi-unsaturated monomer(s) each have a divalent chain length with at least two carbon atoms between at least two of the ethylenically-unsaturated groups, and constitute from 8% by weight to 25% by weight of the monomers used to produce the emulsion-polymerized latex copolymer; wherein the monomers used to produce the emulsion-polymerized latex copolymer are substantially free of oxirane groups, and wherein the coating composition preferably includes less than 1 weight percent, if any, of vegetable oils; one or more mono-unsaturated monomers each having a single ethylenically-unsaturated group; and one or more multi-unsaturated monomers each having two or more ethylenically-unsaturated groups, wherein the multi-unsaturated monomer(s) each have a divalent chain length with at least two carbon atoms between at least two of the ethylenically-unsaturated groups, and constitute from 8% by weight to 25% by weight of the monomers used to produce the emulsion-polymerized latex copolymer; wherein the monomers used to produce the emulsion-polymerized latex copolymer are substantially free of oxirane groups, and wherein the coating composition preferably includes less than 1 weight percent, if any, of vegetable oils; spraying the provided coating composition onto an interior surface of the food or beverage container; and curing the sprayed coating composition to substantially remove the aqueous carrier, and provide the coating on the interior surface of the food or beverage container.
Pipette tip for connection to a pipette tube of a pipetting device, wherein the pipette tip is formed as an elongated tube forming a pipette body having at one first end thereof an opening for aspirating and/or dispensing liquids and being adapted at the other end thereof for connection to the pipette tube, characterized in that the pipette tip has a first electrode as volume measuring electrode of a measuring capacitor and a second electrode as immersion detection electrode, wherein the first electrode is disposed on an outer surface of the pipette body or is embedded in the pipette body, and wherein the first electrode does not extend to the opening at the first end and in particular is spaced from this opening, and the second electrode is disposed at least partially on an inner surface of the pipette body, wherein the first electrode and second electrode are electrically conductive, and the second electrode at least partially galvanically contacts the liquid at the inner surface of the pipette body.
An anti-Folate receptor 1 (FOLR1) antibody or anti-FOLR1 immunoconjugate for use in cancer therapy in a subject, wherein an increased expression of FOLR1 gene or protein in a cancer sample from said subject has been detected using a detection method that distinguishes between staining intensity or staining uniformity in a FOLR1 expressing cancer sample as compared to staining intensity or staining uniformity in one or more reference sample, wherein the efficacy of cancer therapy with an anti-FOLR1 antibody or anti-FOLR1 immunoconjugate has thereby been increased; wherein the anti-FOLR1 antibody for use in cancer therapy comprises: (i) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC), and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 4 (huMov1 9 vLCv1.00) or (ii) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC) and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 5 (huMov19 vLCv1.60); and wherein the anti-FOLR1 immunoconjugate for use in cancer therapy comprises an anti-FOLR1 antibody, a linker, and a cytotoxin, wherein the anti-FOLR1 antibody of the anti-FOLR1 immunoconjugate comprises: (i) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC), and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 4 (huMov19 vLCv1.00) or (ii) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC) and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 5 (huMov19 vLCv1.60). (i) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC), and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 4 (huMov1 9 vLCv1.00) or (ii) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC) and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 5 (huMov19 vLCv1.60); and wherein the anti-FOLR1 immunoconjugate for use in cancer therapy comprises an anti-FOLR1 antibody, a linker, and a cytotoxin, wherein the anti-FOLR1 antibody of the anti-FOLR1 immunoconjugate comprises: (i) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC), and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 4 (huMov19 vLCv1.00) or (ii) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC) and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 5 (huMov19 vLCv1.60). (i) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC), and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 4 (huMov19 vLCv1.00) or (ii) a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO: 3 (huMov19 vHC) and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 5 (huMov19 vLCv1.60).
A method, comprising: presenting content audio in a room; receiving (210, 315) room audio at a consumer electronics device, the room audio including the sounds generated in the room; receiving (210, 310)) the content audio at the consumer electronics device; characterised by dividing (330, 335, 1030, 1035) each of the room audio and content audio into corresponding equal length intervals; extracting features (220, 340, 345, 1040, 1045) from each of the room audio and the content audio; comparing (230, 350, 1050) the features of an interval of the room audio with the features of a temporally corresponding interval of the content audio; and if there is a significant difference between the features of the content audio and the features of the room audio, inferring (240, 370) the presence of one or more people in a room in which the consumer electronics device is located. presenting content audio in a room; receiving (210, 315) room audio at a consumer electronics device, the room audio including the sounds generated in the room; receiving (210, 310)) the content audio at the consumer electronics device; characterised by dividing (330, 335, 1030, 1035) each of the room audio and content audio into corresponding equal length intervals; extracting features (220, 340, 345, 1040, 1045) from each of the room audio and the content audio; comparing (230, 350, 1050) the features of an interval of the room audio with the features of a temporally corresponding interval of the content audio; and if there is a significant difference between the features of the content audio and the features of the room audio, inferring (240, 370) the presence of one or more people in a room in which the consumer electronics device is located.
A safety switch for controlling the access to industrial machines or plants, comprising: - a switching device adapted to be associated with a fixed part of the access to be controlled and having switching means operably connectable to one or more control and/or service circuits of the plants for controlling thereof; - an actuator device adapted to be associated with a movable part of the access to interact with said switching means at the opening/closing of the access for opening/closing one or more of said circuits and passing from a removed condition to an inserted condition; - locking/unlocking means housed in said switching device and adapted to lock said actuator device on said switching device following their mutual interaction; characterized by - an electronic control unit having a first communication channel with a first inlet (IN 1) and a first outlet (OUT 1) and a second communication channel with a second inlet (IN 2) and a second outlet (OUT 2), said communication channels (6, 7) being adapted to receive and transmit information about the locked and open conditions of the accesses according to the state of the corresponding actuator device; wherein said first outlet (OUT 1) and said second outlet (OUT 2) are of safe type and adapted to vary their state after detecting said removed/inserted and/or locked condition of said actuator device; wherein said electronic control unit is adapted to vary the state of said first outlet (OUT 1) and said second outlet (OUT 2) upon detection respectively of a first and a of second condition for said actuator device, wherein said first and said second conditions are different from each other. - a switching device adapted to be associated with a fixed part of the access to be controlled and having switching means operably connectable to one or more control and/or service circuits of the plants for controlling thereof; - an actuator device adapted to be associated with a movable part of the access to interact with said switching means at the opening/closing of the access for opening/closing one or more of said circuits and passing from a removed condition to an inserted condition; - locking/unlocking means housed in said switching device and adapted to lock said actuator device on said switching device following their mutual interaction; - an electronic control unit having a first communication channel with a first inlet (IN 1) and a first outlet (OUT 1) and a second communication channel with a second inlet (IN 2) and a second outlet (OUT 2), said communication channels (6, 7) being adapted to receive and transmit information about the locked and open conditions of the accesses according to the state of the corresponding actuator device;
A method of wireless communication at a user equipment, UE, comprising: transmitting a first uplink message during a transmission time interval, TTI, in a first frequency band of a system bandwidth; transmitting signaling indicative of a retuning capability of the UE, wherein the retuning capability indicates a duration for the UE to retune based at least in part on a number of symbols for UE retuning; retuning a transmitter to a second frequency band of the system bandwidth during a first portion of a second TTI, wherein the second TTI directly follows the first TTI and a duration of the first portion of the second TTI is based at least in part on the duration for the UE to retune indicated by the retuning capability, the retuning capability being based at least in part on a coverage enhancement requirement of the UE; and transmitting a second uplink message during a second portion of the second TTI in the second frequency band. transmitting a first uplink message during a transmission time interval, TTI, in a first frequency band of a system bandwidth; transmitting signaling indicative of a retuning capability of the UE, wherein the retuning capability indicates a duration for the UE to retune based at least in part on a number of symbols for UE retuning; retuning a transmitter to a second frequency band of the system bandwidth during a first portion of a second TTI, wherein the second TTI directly follows the first TTI and a duration of the first portion of the second TTI is based at least in part on the duration for the UE to retune indicated by the retuning capability, the retuning capability being based at least in part on a coverage enhancement requirement of the UE; and transmitting a second uplink message during a second portion of the second TTI in the second frequency band.
A system for treating an exhaust gas comprising a catalyst article comprising: a. a first SCR catalyst zone comprising vanadium loaded on a metal oxide selected from TiO 2, ZrO 2, SiO 2, CeO 2, and Al 2 O 3; and b. a second SCR catalyst zone comprising a copper loaded small-pore molecular sieve, wherein the first SCR catalyst zone is disposed upstream of the second SCR catalyst zone with respect to normal exhaust gas flow through the system, and wherein the first SCR catalyst zone has a higher washcoat loading relative to the second SCR catalyst zone; and the catalyst article has an overall copper loading that is higher than an overall vanadium loading. a. a first SCR catalyst zone comprising vanadium loaded on a metal oxide selected from TiO 2, ZrO 2, SiO 2, CeO 2, and Al 2 O 3; and b. a second SCR catalyst zone comprising a copper loaded small-pore molecular sieve, wherein the first SCR catalyst zone is disposed upstream of the second SCR catalyst zone with respect to normal exhaust gas flow through the system, and wherein the first SCR catalyst zone has a higher washcoat loading relative to the second SCR catalyst zone; and the catalyst article has an overall copper loading that is higher than an overall vanadium loading.
A compound of formula I wherein A 1 is phenyl or a five or six membered hereroaryl group, containing 1, 2 or 3 heteroatoms, selected from N or S; R 1 is hydrogen, C 1-7 -alkyl, halogen, C 1-7 -alkyl substituted by halogen or cycloalkyl; A 2 is phenyl; R 2 is halogen, C 1-7 -alkyl, C 1-7 -alkyl substituted by halogen, C 1-7 -alkoxy substituted by halogen, cyano, S-C 1-7 -alkyl substituted by halogen, S 2 -C 1-7 -alkyl substituted by halogen; n is 1 or 2; or a pharmaceutically acceptable acid addition salt, a racemic mixture or its corresponding enantiomer and/or optical isomers thereof for use in the treatment of autism, stress, including post traumatic stress disorder, anxiety, including anxiety disorders and depression, schizophrenia, psychiatric disorders and memory loss, alcohol withdrawal drug addiction and for use in treatment of Prader-Willi Syndrom. A 1 is phenyl or a five or six membered hereroaryl group, containing 1, 2 or 3 heteroatoms, selected from N or S; R 1 is hydrogen, C 1-7 -alkyl, halogen, C 1-7 -alkyl substituted by halogen or cycloalkyl; A 2 is phenyl; R 2 is halogen, C 1-7 -alkyl, C 1-7 -alkyl substituted by halogen, C 1-7 -alkoxy substituted by halogen, cyano, S-C 1-7 -alkyl substituted by halogen, S 2 -C 1-7 -alkyl substituted by halogen; n is 1 or 2;
High-pressure discharge lamp having an elongate discharge vessel as a single piston which defines an axial axis of symmetry and which is closed at two sides by means of seals and which surrounds a discharge volume, wherein two electrodes whose shafts are connected to foils face each other on the axis, and which contains an ionisable filling of mercury, noble gas and metal halides, and having electric current leads which are connected to the electrodes by means of foils and which are extend from the ends of the discharge vessel, wherein the lamp consumes a power of at least 1600 W, characterised in that the shafts are constructed as pins with a diameter of from 0.5 to 1.15 mm, and in that the halogen for the halides is composed of the components iodine and optionally bromine, wherein either only iodine or bromine and iodine together is/are used, wherein the atomic ratio bromine/iodine is a maximum of 1.45 and in particular is in the range from 0.8 to 1.2.